Photo: ljubaphoto / E+ / Getty Images
Researchers in South Korea have developed an artificial intelligence-based diagnostic tool that can distinguish between osteoarthritis (OA) and rheumatoid arthritis (RA) with 98% accuracy. This groundbreaking tool analyzes synovial fluid, the lubricating liquid in joints, to differentiate between the two conditions, which share similar symptoms but have different causes and treatments. The study was published in the journal Small.
The new diagnostic platform, developed by the Korea Institute of Materials Science (KIMS) in collaboration with Seoul St. Mary's Hospital, uses a technique called Surface-Enhanced Raman Scattering (SERS) to detect tiny molecular signals in synovial fluid. The system employs a sensor made of sea urchin-shaped gold nanostructures on paper, which enhances the Raman signal from the joint fluid. Machine learning algorithms, including a support vector machine (SVM), process the data to classify the samples, achieving 97.3% sensitivity and 100% specificity in distinguishing between OA and RA.
According to StudyFinds, the tool not only differentiates between OA and RA but also assesses the severity of RA by analyzing white blood cell counts in patient samples. This rapid diagnostic method is more accurate and cost-effective than traditional methods like X-rays, MRI, and blood tests, which can be time-consuming and inconclusive in early disease stages.
The research team, led by Dr. Ho Sang Jung, envisions the technology becoming a valuable tool in healthcare, particularly as a pre-screening method before more expensive imaging diagnostics. The platform's simplicity, speed, and accuracy make it a promising alternative to conventional blood tests.
While the study shows impressive results, the researchers acknowledge some limitations, such as the need for broader clinical validation and multi-center studies to strengthen the findings. The team plans to expand their research to cover a wider range of diseases in the future.